Amanda Harrington

2.6k total citations · 1 hit paper
53 papers, 1.1k citations indexed

About

Amanda Harrington is a scholar working on Clinical Biochemistry, Infectious Diseases and Epidemiology. According to data from OpenAlex, Amanda Harrington has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Clinical Biochemistry, 16 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Amanda Harrington's work include Bacterial Identification and Susceptibility Testing (18 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Escherichia coli research studies (9 papers). Amanda Harrington is often cited by papers focused on Bacterial Identification and Susceptibility Testing (18 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Escherichia coli research studies (9 papers). Amanda Harrington collaborates with scholars based in United States, Spain and Switzerland. Amanda Harrington's co-authors include William D. Picking, Wendy L. Picking, Eric Wenzler, Jill E. Clarridge, J E Vena, Arthur M. Michalek, Tetsuo Nemoto, Rosemary Laughlin, Jo L. Freudenheim and James R. Marshall and has published in prestigious journals such as Gastroenterology, Biochemistry and Clinical Microbiology Reviews.

In The Last Decade

Amanda Harrington

48 papers receiving 1.1k citations

Hit Papers

Guide to Utilization of the Microbiology Laboratory for D... 2024 2026 2025 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
    2024 62 citations Amanda Harrington et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Harrington United States 17 342 286 271 245 217 53 1.1k
Fabien Garnier France 20 343 1.0× 286 1.0× 317 1.2× 120 0.5× 105 0.5× 78 1.1k
Kotaro Aoki Japan 18 362 1.1× 233 0.8× 293 1.1× 222 0.9× 71 0.3× 97 1.0k
Tarah Lynch Canada 18 430 1.3× 213 0.7× 455 1.7× 186 0.8× 126 0.6× 39 1.2k
G. Młynarczyk Poland 21 502 1.5× 469 1.6× 290 1.1× 130 0.5× 73 0.3× 176 1.4k
Ortrud Zimmermann Germany 19 448 1.3× 226 0.8× 311 1.1× 107 0.4× 89 0.4× 44 1.1k
Forough L. Nowrouzian Sweden 18 361 1.1× 202 0.7× 481 1.8× 564 2.3× 124 0.6× 37 1.3k
Andrea Petrucca Italy 22 183 0.5× 275 1.0× 573 2.1× 404 1.6× 107 0.5× 47 1.5k
Gemma L. Kay United Kingdom 16 281 0.8× 342 1.2× 456 1.7× 79 0.3× 97 0.4× 34 1.2k
J. Croizé France 20 219 0.6× 318 1.1× 307 1.1× 200 0.8× 90 0.4× 78 1.2k
Martin Sundqvist Sweden 18 251 0.7× 377 1.3× 167 0.6× 151 0.6× 73 0.3× 55 1.2k

Countries citing papers authored by Amanda Harrington

Since Specialization
Citations

This map shows the geographic impact of Amanda Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Harrington more than expected).

Fields of papers citing papers by Amanda Harrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Harrington. The network helps show where Amanda Harrington may publish in the future.

Co-authorship network of co-authors of Amanda Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Harrington. A scholar is included among the top collaborators of Amanda Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Harrington. Amanda Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbian, Hannah J., Amanda Harrington, Joshua Carson, et al.. (2025). Candida auris Outbreak and Epidemiologic Response in Burn Intensive Care Unit, Illinois, USA, 2021–2023. Emerging infectious diseases. 31(3). 438–447. 3 indexed citations
2.
Abbott, April N., Kevin Alby, Jennifer Dien Bard, et al.. (2023). Evaluation of Piperacillin-Tazobactam Testing against Enterobacterales by the Phoenix, MicroScan, and Vitek2 Tests Using Updated Clinical and Laboratory Standards Institute Breakpoints. Journal of Clinical Microbiology. 61(2). e0161722–e0161722. 9 indexed citations
3.
4.
Harrington, Amanda, Maria M. Traczewski, Sharon DesJarlais, et al.. (2023). A-273 Multicenter Assessment of the Accuracy of MIC Results for Piperacillin/Tazobactam with MicroScan Dried Gram-Negative MIC Panels using CLSI Breakpoints. Clinical Chemistry. 69(Supplement_1).
5.
Harrington, Amanda, et al.. (2022). Clinical Manifestations and Stool Load of Atypical Enteropathogenic Escherichia coli Infections in United States Children and Adults. Gastroenterology. 163(5). 1321–1333. 9 indexed citations
6.
Wenzler, Eric, Maressa Santarossa, Kevin A. Meyer, et al.. (2020). In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient. Open Forum Infectious Diseases. 7(1). ofz545–ofz545. 6 indexed citations
7.
Meyer, Kevin A., et al.. (2019). Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model. International Journal of Antimicrobial Agents. 54(2). 197–201. 11 indexed citations
8.
Harrington, Amanda, et al.. (2017). Deep brain stimulator infection by a novel rapid growing mycobacterium. Acta Neurochirurgica. 159(11). 2239–2241. 5 indexed citations
9.
10.
11.
Ruíz, Laura, et al.. (2017). Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis. Value in Health. 20(9). A724–A724. 1 indexed citations
12.
Harrington, Amanda, et al.. (2017). Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile. Annals of Clinical Microbiology and Antimicrobials. 16(1). 77–77. 7 indexed citations
13.
Tsoukas, Maria, et al.. (2016). Cutaneous Nocardiosis: A Conspicuous Eyelid Eschar. The Journal of Pediatrics. 177. 327–327. 2 indexed citations
14.
Harrington, Amanda & Jill E. Clarridge. (2013). Impact of identification of Streptococcus dysgalactiae subspecies equisimilis from throat cultures in an adult population. Diagnostic Microbiology and Infectious Disease. 76(1). 20–23. 5 indexed citations
15.
Rouleau, Tanya, Amanda Harrington, Michael T. Brennan, et al.. (2011). Receipt of dental care and barriers encountered by persons with disabilities. Special Care in Dentistry. 31(2). 63–67. 23 indexed citations
16.
Harrington, Amanda, Claire J. Creutzfeldt, Dhruba J. SenGupta, et al.. (2008). Diagnosis of Neurocysticercosis by Detection ofTaenia soliumDNA Using a Global DNA Screening Platform. Clinical Infectious Diseases. 48(1). 86–90. 22 indexed citations
17.
Harrington, Amanda, et al.. (2007). Differentiation of Candida albicans from non-albicans yeast directly from blood cultures by Gram stain morphology. European Journal of Clinical Microbiology & Infectious Diseases. 26(5). 325–329. 23 indexed citations
18.
Picking, Wendy L., Hiroaki Nishioka, M. Baxter, et al.. (2005). IpaD of Shigella flexneri Is Independently Required for Regulation of Ipa Protein Secretion and Efficient Insertion of IpaB and IpaC into Host Membranes. Infection and Immunity. 73(3). 1432–1440. 114 indexed citations
19.
Picking, Wendy L., et al.. (2001). IpaC from Shigella and SipC from Salmonella possess similar biochemical properties but are functionally distinct. Molecular Microbiology. 42(2). 469–481. 40 indexed citations
20.
Ferrari, Deborah, Amanda Harrington, Caroline N. Dealy, & Robert A. Kosher. (1999). Dlx-5 in limb initiation in the chick embryo. Developmental Dynamics. 216(1). 10–15. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabien Garnier Breakdown of academic impact, for papers by Kotaro Aoki Breakdown of academic impact, for papers by Tarah Lynch Breakdown of academic impact, for papers by G. Młynarczyk Breakdown of academic impact, for papers by Ortrud Zimmermann Breakdown of academic impact, for papers by Forough L. Nowrouzian Breakdown of academic impact, for papers by Andrea Petrucca Breakdown of academic impact, for papers by Gemma L. Kay Breakdown of academic impact, for papers by J. Croizé Breakdown of academic impact, for papers by Martin Sundqvist
Rankless by CCL
2026